e-Posters - Clinical Cardiology 2018
Lianita Gumdani
Mekarsari Hospital, Bekasi, West Java, Indonesia
STEMI PATIENT IN TYPE-C HOSPITAL : TO TREAT OR NOT TO TREAT ?
Lianita Gumdani(Biography)
Lianita Gumdani has complete my medical doctor in 2017 at Christian University of Indonesia. Now I still being internship doctor in Mekarsari horpital, Bekasi, west java, Indonesia.
Lianita Gumdani(Abstract)
ST-elevated myocardial infarction (STEMI) caused by complete occlusion of an epicardial coronary artery. Revascularization is mandatory in saving infark related teritory. In JKN (Indonesian National Health Insurance) era, there are some limitacy of type-C hospital in managing STEMI patient and there is no report of primary-PCI. Fibrinolytic become an option with onset less than 12 hours. We conducted a descriptive study, data taken from medical records between April 2014- January 2018. STEMI was diagnose from symptoms and ECG pattern. There were 48 STEMI patients with onset less than 12 hours (42 males and 6 females). The mean age was 52 years old with the oldest 74 years old and the youngest 30 years old. All of them 48 (100%) patients were covered by JKN and received fibrinolytic therapy with door-to-needle mean time was 28,87 minutes and in-hospital mortality rate was 8,3% (4 patients). The most risk factor of STEMI is hypertension (47,9%). There were 12 patients came with onset more than 12 hours. Type-C hospital during JKN era can contribute to optimal management of STEMI patient by delivering fibrinolytic theraphy. Hypertension was still the most common risk factor for STEMI patients.